Horacio Herrera-Fajer is an accomplished strategist specializing in driving clinical trial landscape, while developing lead generation across new channels. As part of the core team, he helped launch Galleri, the first ever multi-cancer early detection blood test. He serves as the Head of Life Insurance Partnerships by showcasing how offering Galleri can help stage shift cancer and with that help bend the mortality curve. Prior to joining Grail in 2020, he led corporate development at Science 37. His entrepreneurial mindset and natural curiosity have guided him to identify opportunities to close gaps and build company revenue. He holds a degree in Political Science and Government from Yale University. He is fluent in English, Spanish and some Chinese.